Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-09-2020 | Diabetic Retinopathy | Retinal Disorders

Removal of foveal hard exudates by subretinal balanced salt solution injection using 38-gauge needle in diabetic patients

Authors: Kazuyuki Kumagai, Nobuchika Ogino, Marie Fukami, Mariko Furukawa

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 9/2020

Abstract

Purpose

To examine the anatomic and visual outcomes after removal of foveal hard exudates through a macular hole created by subretinal balanced salt solution (BSS) injection.

Methods

This was a retrospective, consecutive, case series. Six patients (7 eyes) underwent vitrectomy with removal of foveal hard exudates. All patients were women and the mean age was 65 years (range from 55 to 71). All patients had a history of panretinal photocoagulation. Previous treatments included intravitreal anti-vascular endothelial growth factor injection in one eye and vitrectomy in both eyes of one patient. The geometric mean preoperative decimal visual acuity was 0.11 (range from 0.08 to 0.3). The mean postoperative follow-up period was 12 months (range from 6 to 19). The status of lens was two phakic and five pseudophakic. Surgical procedures included simultaneous cataract surgery if phakic, creation of posterior vitreous detachment if not present, internal limiting membrane (ILM) peeling and a gas or air tamponade. Manual subretinal BSS injection using 38-gauge needle was performed at ILM-peeled area. Removal of foveal hard exudates was conducted by the water flow through the macular hole created during subretinal BSS injection.

Results

Foveal hard exudates decreased in all cases early after surgery. The geometric mean final decimal visual acuity was 0.31 (range from 0.1 to 0.9). Visual acuity improved more than 0.2 LogMAR units in six eyes and unchanged in one eye. There was no severe complication and recurrence of macular edema.

Conclusion

This procedure may be effective for foveal hard exudates in diabetic patients.

Available only for authorised users

Klein BE, Moss SE, Klein R, Surawicz TS (1991) The Wisconsin epidemiologic study of diabetic retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 98:1261–1265CrossRef

Chew EY, Klein ML, Ferris FL 3rd, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ, Miller D (1996) Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol 114:1079–1084CrossRef

Fong DS, Segal PP, Myers F, Ferris FL, Hubbard LD, Davis MD (1997) Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol 115:873–877CrossRef

Møller F, Bek T (2003) The relation between visual acuity, fixation stability, and the size and location of foveal hard exudates after photocoagulation for diabetic maculopathy: a 1-year follow-up study. Graefes Arch Clin Exp Ophthalmol 241:458–462CrossRef

Nakamura Y, Tatsumi T, Arai M, Takatsuna Y, Mitamura Y, Yamamoto S (2009) Subthreshold micropulse diode laser photocoagulation for diabetic macular edema with hard exudates. Nippon Ganka Gakkai Zasshi 113:787–791 Article in JapanesePubMed

Deák GG, Bolz M, Kriechbaum K, Prager S, Mylonas G, Scholda C, Schmidt-Erfurth U, Diabetic Retinopathy Research Group Vienna (2010) Effect of retinal photocoagulation on intraretinal lipid exudates in diabetic macular edema documented by optical coherence tomography. Ophthalmology 117:773–779. https://doi.org/10.1016/j.ophtha.2009.09.027CrossRefPubMed

Gordon B, Chang S, Kavanagh M, Berrocal M, Yannuzzi L, Robertson C, Drexler A (1991) The effects of lipid lowering on diabetic retinopathy. Am J Ophthalmol 112:385–391CrossRef

Gupta A, Gupta V, Thapar S, Bhansali A (2004) Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthalmol 137:675–682PubMed

Kawasaki R, Konta T, Nishida K (2018) Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: a real-world observational analysis of a health claims database. Diabetes Obes Metab 20:2351–2360CrossRef

10.

Kang EY, Chen TH, Garg SJ, Sun CC, Kang JH, Wu WC, Hung MJ, Lai CC, Cherng WJ, Hwang YS (2019) Association of statin therapy with prevention of vision-threatening diabetic retinopathy. JAMA Ophthalmol 137:363–371. https://doi.org/10.1001/jamaophthalmol.2018.6399CrossRefPubMedPubMedCentral

11.

Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S (2004) Intravitreal triamcinolone for the treatment of refractory diabetic macular edema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 88:1131–1136CrossRef

12.

Khairallah M, Zeghidi H, Ladjimi A, Yahia SB, Attia S, Zaouali S, Messaoud R (2005) Primary intravitreal triamcinolone acetonide for diabetic massive macular hard exudates. Retina 25:835–839CrossRef

13.

Avci R, Kaderli B (2006) Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates. Graefes Arch Clin Exp Ophthalmol 244:28–35CrossRef

14.

Cekiç O, Bardak Y, Tiğ US, Yildizoğlu U, Bardak H (2008) Quantitative evaluation of reduction of plaque-like hard exudates in diabetic macular edema after intravitreal triamcinolone injection. Int Ophthalmol 28:95–99CrossRef

15.

Larsson J, Kifley A, Zhu M, Wang JJ, Mitchell P, Sutter FK, Gillies MC (2009) Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial. Acta Ophthalmol 87:275–280. https://doi.org/10.1111/j.1755-3768.2008.01245.xCrossRefPubMed

16.

Pemp B, Deák G, Prager S, Mitsch C, Lammer J, Schmidinger G, Scholda C, Schmidt-Erfurth U, Bolz M, Diabetic Retinopathy Research Group Vienna (2014) Distribution of intraretinal exudates in diabetic macular edema during anti-vascular endothelial growth factor therapy observed by spectral domain optical coherence tomography and fundus photography. Retina 34:2407–2415. https://doi.org/10.1097/IAE.0000000000000250CrossRefPubMed

17.

Domalpally A, Ip MS, Ehrlich JS (2015) Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials. Ophthalmology 122:779–786. https://doi.org/10.1016/j.ophtha.2014.10.028CrossRefPubMed

18.

Jeon S, Lee WK (2014) Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates. Clin Ophthalmol 8:1479–1486. https://doi.org/10.2147/OPTH.S66405 eCollection 2014CrossRefPubMedPubMedCentral

19.

Thomas MA, Grand MG, Williams DF, Lee CM, Pesin SR, Lowe MA (1992) Surgical management of subfoveal choroidal neovascularization. Ophthalmology 99:952–968 discussion 975-976CrossRef

20.

Takagi H, Otani A, Kiryu J, Ogura Y (1999) New surgical approach for removing massive foveal hard exudates in diabetic macular edema. Ophthalmology 106:249–256 discussion 256-257CrossRef

21.

Sakuraba T, Suzuki Y, Mizutani H, Nakazawa M (2000) Visual improvement after removal of submacular exudates in patients with diabetic maculopathy. Ophthalmic Surg Lasers 31:287–291PubMed

22.

Kumagai K, Ogino N, Furukawa M, Demizu S, Atsumi K, Kurihara H, Iwaki M, Ishigooka H, Tachi N (2002) Surgical removal of subfoveal hard exudates in diabetic maculopathy]. [Article in Japanese. Nippon Ganka Gakkai Zasshi 106:595–601PubMed

23.

Furukawa M, Kumagai K, Ogino N, Demizu S, Ishigooka H, Tachi N (2003) Subretinal washout for subtle subfoveal hard exudates in diabetic macular edema. Nippon Ganka Gakkai Zasshi 107:369–374 Article in JapanesePubMed

24.

Takaya K, Suzuki Y, Mizutani H, Sakuraba T, Nakazawa M (2004) Long-term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy. Retina 24:23–29CrossRef

25.

Avci R, Inan UU, Kaderli B (2008) Long-term results of excision of plaque-like foveal hard exudates in patients with chronic diabetic macular oedema. Eye (Lond) 22:1099–1104CrossRef

26.

Naito T, Matsushita S, Sato H, Katome T, Nagasawa T, Shiota H (2008) Results of submacular surgery to remove diabetic submacular hard exudates. J Med Investig 55:211–215CrossRef

27.

Morizane Y, Kimura S, Hosokawa M, Shiode Y, Hirano M, Doi S, Hosogi M, Fujiwara A, Inoue Y, Shiraga F (2015) Planned foveal detachment technique for the resolution of diffuse diabetic macular edema. Jpn J Ophthalmol 59:279–287. https://doi.org/10.1007/s10384-015-0390-4CrossRefPubMed

28.

Abdel Hadi AM (2018) Evaluation of vitrectomy with planned foveal detachment as surgical treatment for refractory diabetic macular edema with or without vitreomacular interface abnormality. J Ophthalmol 2018:9246384. https://doi.org/10.1155/2018/9246384 eCollection 2018CrossRefPubMedPubMedCentral

29.

Yang CM (2000) Surgical treatment for severe diabetic macular edema with massive hard exudates. Retina 20:121–125CrossRef

30.

Kumagai K, Furukawa M, Suetsugu T, Ogino N (2017) Increase in average foveal thickness after internal limiting membrane peeling. Clin Ophthalmol 11:605–611. https://doi.org/10.2147/OPTH.S134909 eCollection 2017CrossRefPubMedPubMedCentral

31.

Kumagai K, Ogino N, Furukawa M, Ooya R, Horie E (2018) Early centripetal displacements of capillaries in macular region caused by internal limiting membrane peeling. Clin Ophthalmol 12:755–763. https://doi.org/10.2147/OPTH.S158826 eCollection 2018CrossRefPubMedPubMedCentral

Title: Removal of foveal hard exudates by subretinal balanced salt solution injection using 38-gauge needle in diabetic patients
Authors: Kazuyuki Kumagai
Nobuchika Ogino
Marie Fukami
Mariko Furukawa
Publication date: 01-09-2020
Publisher: Springer Berlin Heidelberg
Keywords: Diabetic Retinopathy
Edema
Diabetic Retinopathy
Vitrectomy
Peeling
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 9/2020
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-020-04756-y

ACC 2024 Congress

Springer Medicine

Removal of foveal hard exudates by subretinal balanced salt solution injection using 38-gauge needle in diabetic patients

Abstract

Purpose

Methods

Results

Conclusion

ACC 2024 Congress

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 9/2020

Diagnosis and management of three optic neuropathies: a national survey

Preoperative factors to select vitrectomy or scleral buckling for retinal detachment in microincision vitrectomy era

Effects of inverted internal limiting membrane technique and insertion technique on outer retinal restoration associated with glial proliferation in large macular holes

Prospective study of morphologic and functional parameter changes post intravitreal therapy for macular edema

Binocular discrepancy in lateral rectus muscle attachment in intermittent exotropia with eye dominance

Ocular manifestations of coronavirus disease 2019